Market-View-Feature-Image

View on market: Volatility Prevails, Market is searching for better value

On Thursday, most Asian markets saw gains, and Australia’s equity indices were trading close to a two-year high. The Krospi was up 0.22% at 2,619.15, while the S&P/ASX 200 was up 0.44%, or 33.48 points, at 7,594.70. Japan’s stock indexes had a decline on Thursday; as of 06:14 a.m., the Nikkei was down 0.73% at 33,434.55. As of Wednesday, the Nasdaq 100 and S&P 500 indexes had increased by 0.17% and 0.14%, respectively. By 0.30%, the Dow Jones Industrial Average increased. At $79.65 per barrel, Brent crude was down 1.75% on the market. An ounce of gold was trading at $2,080.66, up 0.15%.

Economic Calendar:

  • USD : Initial Jobless Claims on 28th December, 2023
  • USD : Pending Home Sales (MoM) (Nov) on 28th December, 2023
  • INR : FX Reserves, USD on 29th December, 2023
  • INR : RBI Monetary and Credit Information Review on 29th December, 2023

Brokerage Radar:

JEFFERIES ON BANKS: While banks offer higher rates, large banks are offering lower rates & in some cases termrates are lower savings rates of small banks. Among smaller bks, IIB has lower rates & wider sources. Lower NIMs may be risk to earnings, but expect some offsets

MS ON AARTI IND: OW, TP Rs 575; Co announced has secured a new, 9-yr, long-term supply contract for a niche agrochemical intermediate from a global agrochem major; Agrochemicals makes up one-third of Co’s revenue; Contract implies annual rev of $40mn; Assuming Aarti’s mid-cycle EBITDA margins of 18%, contract implies 3-4% accretion to EBITDA & 6-7% accretion to earnings over F2025-26.

International Markets:

U.S & Europe:

Particulars 27th December Chg. Chg.(%)
Nasdaq 15077.40 2.83 0.02
Dow 37656.52 111.19 0.30
FTSE 7724.95 27.44 0.36
CAC 7571.82 3.00 0.04
DAX 16742.07 35.89 0.21
Dow Fut.* 37714.17 57.65 0.15

Asian markets:

Particulars 28th  December Chg. Chg.(%)
GIFT Nifty 21740.00 70.00 0.32
Nikkei 33503.94 -177.30 -0.53
Straits Times 3222.33 51.57 1.63
Hang Seng 16875.05 250.21 1.51
Shanghai 2943.18 28.57 0.98

ADR Watch:

Particulars 27th December  Chg.       Chg.(%)
Dr. Reddy 68.15 0.87 1.29
HDFC Bank 67.02 0.30 0.45
ICICI Bank 24.02 0.14 0.59
Infosys 18.62 0.17 0.92
Wipro 5.57 0.06 1.00

Commodities & Currency:

Particulars Current Price Chg.(%)
USD/INR 83.27 0.02
Brent 79.63 0.11
Gold 2097.55 0.21
Silver 24.69 0.19

FIIs & DIIs:

Particulars 27th December 26th December
FIIs                          2926.05 -95.20
DIIs -192.01 167.04

News Update:

Housing and Urban Development Corp: The company executed a Memorandum of Understanding with the Gujarat government for an investment of up to Rs 14,500 crore for financing housing and urban infrastructure projects.

Power Finance Corp, Tata Power: PFC subsidiary Bikaner III Neemrana II Transmission has been transferred to Tata Power for Rs 18.60 crore and Neemrana Il Kotputli Transmission has been transferred to Sterlite Grid 32 for Rs 18.59 crore.

Power Grid Corp: The company has acquired Bikaner III Neemrana Transmission in Rajasthan under a tariff-based competitive bidding route for Rs 18.82 crore.

Exide Industries: The company has made an investment of Rs 40 crore in its arm, Exide Energy Solutions. The total investment in its arm now stands at Rs 1,820.01 crore.

GE Power India: The company received an order worth Rs 10.47 crore from NTPC to supply generator spares and received an order worth Rs 9.91 crore from Bokaro Power Supply Co. for the supply of spares.

Affle India: The company has approved to enter a non-binding Memorandum of Understanding to invest Rs 37.3 crore as cash consideration to acquire minority ownership in the travel social media app Explurger.

Kotak Mahindra Bank: The Reserve Bank of India has approved the appointment of CS Rajan, Independent Director, as the part-time chairman for a period of two years, effective Jan. 1, 2024.

Life Insurance Corp: The company appointed S. Sunder Krishnan as chief risk officer, effective Dec. 27.

Lupin: The pharma major announced that it has received approval from the USFDA for its abbreviated new drug application for Loteprednol Etabonate Ophthalmic Suspension.

Reliance Capital: The Competition Commission approved the proposed acquisition of the stake in Reliance Capital by IndusInd International Holdings, IIHL BFSI (India) and Aasia Enterprises LLP.

Canara Bank: The bank has approved the process of listing its mutual fund subsidiary, Canara Robeco Asset Management Company, by way of an IPO.

Dabur India: The dissolution of the company’s subsidiary, Dabur Tunisia, is delayed till Dec. 31, 2024, as the response from the Reserve Bank and authorities in Tunisia on the matter is still awaited.

City Union Bank: The company opened four new branches on Dec. 27.

PTC Industries: The company and Nasmyth signed a Memorandum of Understanding for collaboration to leverage their capabilities for offering solutions to defence and aerospace customers in India and globally.

Source: Moneycontrol, Bloomberg Quint, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

  1. Reports
  2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

  1. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.